Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(8):617-629; doi:10.1093/jnci/94.8.617
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Syed, V.
Right arrow Articles by Ho, S.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Syed, V.
Right arrow Articles by Ho, S.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 8, 617-629, April 17, 2002
© 2002 Oxford University Press


ARTICLE

Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells

Viqar Syed, Gregory Ulinski, Samuel C. Mok, Shuk-Mei Ho

Affiliations of authors: V. Syed (Department of Surgery), S.-M. Ho (Department of Surgery and Cell Biology), University of Massachusetts Medical School, Worcester; G. Ulinski, Worcester Polytechnic Institute, Worcester; S. C. Mok, Laboratory of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston.

Correspondence to: Shuk-Mei Ho, Ph.D., Department of Surgery, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655 (e-mail: shuk-mei.ho{at}umassmed.edu).

Background: Reproductive hormones are associated with risk for epithelial ovarian cancer. To determine the effect of such hormones on the activation of interleukin 6 (IL-6)/STAT3 (signal transducer and activator of transcription-3) signaling, which may be involved in ovarian cancer, we investigated the status of STAT3, IL-6, and its receptor in immortalized human ovarian surface epithelial (HOSE) and ovarian cancer (OVCA) cell lines. Methods: Two immortalized HOSE cell lines and two OVCA cell lines were cultured with gonadotropins, sex steroid hormones, and/or IL-6, alone or with specific inhibitors or IL-6-neutralizing antibodies. Expression of IL-6, the IL-6 receptor {alpha} chain (IL-6R{alpha}), and phosphorylated and unphosphorylated STAT3 messenger RNAs (mRNAs) and proteins in all cells was determined. Cell proliferation and soft-agar colony formation were assessed. STAT3 activity was investigated in OVCA cells transfected with a dominant negative STAT3 (Dn-STAT3), wild-type STAT3, or an empty control vector. All statistical tests were two-sided. Results: Levels of IL-6 mRNA and protein increased in all cells treated with follicle-stimulating hormone (FSH), luteinizing hormone (LH), 17{beta}-estradiol, or estrone but increased only in OVCA cells treated with testosterone and 5{alpha}-dihydrotestosterone. For all lines, IL-6 antibodies partially inhibited hormone-stimulated cell proliferation but completely inhibited IL-6-enhanced cell proliferation. IL-6 induced STAT3 phosphorylation and activation in HOSE cells; STAT3 was constitutively activated in OVCA cells. Higher levels of IL-6R{alpha} and STAT3 transcription factors were observed in OVCA cells than in HOSE cells. After transfection, Dn-STAT3 suppressed endogenous STAT3 and inhibited all forms of IL-6-stimulated OVCA cell proliferation (OVCA 429 cells, P<.001; OVCA 432 cells, P<.006), whereas wild-type STAT3 enhanced HOSE cell proliferation (wild-type STAT3 at 0.5 µg/mL in HOSE 306 cells, P<.002; STAT3 at 1.0 µg/mL in HOSE 306 or both concentrations of wild-type STAT3 in HOSE 642 cells, P<.001). Conclusions: The IL-6/STAT3 signaling pathway may mediate FSH-, LH-, and estrogen-stimulated HOSE cell proliferation. Increased IL-6R{alpha} expression and constitutive STAT3 activation may be associated with ovarian cancer.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Z. Duan, J. Bradner, E. Greenberg, R. Mazitschek, R. Foster, J. Mahoney, and M. V. Seiden
8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic Acid (SD-1008), a Novel Janus Kinase 2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells
Mol. Pharmacol., November 1, 2007; 72(5): 1137 - 1145.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung
Gonadotropins and Ovarian Cancer
Endocr. Rev., June 1, 2007; 28(4): 440 - 461.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. C.K. Leung and J.-H. Choi
Endocrine signaling in ovarian surface epithelium and cancer
Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kulbe, R. Thompson, J. L. Wilson, S. Robinson, T. Hagemann, R. Fatah, D. Gould, A. Ayhan, and F. Balkwill
The Inflammatory Cytokine Tumor Necrosis Factor-{alpha} Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer Cells
Cancer Res., January 15, 2007; 67(2): 585 - 592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. F. Liu, R. K. H. Lo, C. S. S. Wong, C. Morris, H. Wise, and Y. H. Wong
Activation of STAT3 by G{alpha}s Distinctively Requires Protein Kinase A, JNK, and Phosphatidylinositol 3-Kinase
J. Biol. Chem., November 24, 2006; 281(47): 35812 - 35825.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Duan, J. E. Bradner, E. Greenberg, R. Levine, R. Foster, J. Mahoney, and M. V. Seiden
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation.
Clin. Cancer Res., November 15, 2006; 12(22): 6844 - 6852.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C.K. Leung
Gonadotropins Activate Proteolysis and Increase Invasion through Protein Kinase A and Phosphatidylinositol 3-Kinase Pathways in Human Epithelial Ovarian Cancer Cells.
Cancer Res., April 1, 2006; 66(7): 3912 - 3920.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. B. Nilsson, R. R. Langley, and I. J. Fidler
Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine
Cancer Res., December 1, 2005; 65(23): 10794 - 10800.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. L. Drakes, T. G. Blanchard, and S. J. Czinn
Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis
J. Leukoc. Biol., December 1, 2005; 78(6): 1291 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Nishimoto, Y. Yu, Z. Lu, X. Mao, Z. Ren, S. S. Watowich, G. B. Mills, W. S-L. Liao, X. Chen, R. C. Bast Jr., et al.
A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer Cells
Cancer Res., August 1, 2005; 65(15): 6701 - 6710.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C K Leung
Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells
Endocr. Relat. Cancer, June 1, 2005; 12(2): 407 - 421.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Allavena, M. Signorelli, M. Chieppa, E. Erba, G. Bianchi, F. Marchesi, C. O. Olimpio, C. Bonardi, A. Garbi, A. Lissoni, et al.
Anti-inflammatory Properties of the Novel Antitumor Agent Yondelis (Trabectedin): Inhibition of Macrophage Differentiation and Cytokine Production
Cancer Res., April 1, 2005; 65(7): 2964 - 2971.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-H. Chou, L.-H. Wei, M.-L. Kuo, Y.-J. Huang, K.-P. Lai, C.-A. Chen, and C.-Y. Hsieh
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor
Carcinogenesis, January 1, 2005; 26(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C. K. Leung
Overexpression of Follicle-Stimulating Hormone Receptor Activates Oncogenic Pathways in Preneoplastic Ovarian Surface Epithelial Cells
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5508 - 5516.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-P. Herbeuval, E. Lelievre, C. Lambert, M. Dy, and C. Genin
Recruitment of STAT3 for Production of IL-10 by Colon Carcinoma Cells Induced by Macrophage-Derived IL-6
J. Immunol., April 1, 2004; 172(7): 4630 - 4636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Steiner, S. Godoy-Tundidor, H. Rogatsch, A. P. Berger, D. Fuchs, B. Comuzzi, G. Bartsch, A. Hobisch, and Z. Culig
Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway
Am. J. Pathol., February 1, 2003; 162(2): 655 - 663.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. Auersperg and H. Ziltener
Re: Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells
J Natl Cancer Inst, August 21, 2002; 94(16): 1255 - 1256.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.